Moreover, the EETs analog and sEH inhibitors also show the strong anti-inflammatory properties in many systematic illnesses, such as heart failure, diabetes, neuro-inflammatory pains, suggesting that pharmacological manipulations of AA-CYP450-EETs-sEH systems are of great potential in clinical applications. This evidence concerns the gene EPHX2 and heart failure.